Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TIL compared with OM: revenue, margins and what each company keeps, and the suppliers and customers both name
TIL
Instil Bio, Inc.
Change
Mkt cap
Revenue
Revenue
OM
Outset Medical, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
TIL
Instil Bio, Inc.
vs
OM
Outset Medical, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
TIL
Instil Bio, Inc.
Change
6.83
▼
−2.29%
· post 6.83
Mkt cap
$47.4M
Revenue
—
Revenue
—
OM
Outset Medical, Inc.
Change
4.20
▲
+2.44%
· post 4.20
Closed
Nov 6 '26
Mkt cap
$77.4M
Revenue
$34M
Q3 FY26
Revenue
$119M
FY25
vs
Compare
Closed
Nov 6 '26
TIL
Instil Bio, Inc.
vs
OM
Outset Medical, Inc.
6.83
▼
−2.29%
post 6.83
Price
4.20
▲
+2.44%
post 4.20
$47.4M
Mkt cap
$77.4M
—
Revenue
$34M
Q3 FY26
—
Revenue
$119M
FY25
Change
Change
TIL
6.83
▼
−2.29%
vs
OM
4.20
▲
+2.44%
Closed
Nov 6 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only TIL
2
AZN
AstraZeneca Pharmaceuticals
customer
—
ImmuneOnco Biopharmaceuticals (Shanghai)
unlisted
supplier
Shared
0
No shared counterparties.
Only OM
1
—
Tacna
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR